Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 8 Similar Profiles
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Tumor-Infiltrating Lymphocytes Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications 2006 2017

  • 118 Citations
  • 5 h-Index
  • 19 Article
  • 2 Review article
  • 1 Chapter

Accelerated leukemic transformation after haplo-identical transplantation for hydroxyurea-treated sickle cell disease

Janakiram, M., Verma, A., Wang, Y., Budhathoki, A., Suarez Londono, J., Murakhovskaya, I., Braunschweig, I. & Minniti, C. P. Jun 6 2017 (Accepted/In press) In : Leukemia and Lymphoma. p. 1-4 4 p.

Research output: Research - peer-reviewArticle

Tumor-Infiltrating Lymphocytes
Residual Neoplasm
Breast Neoplasms
Drug Therapy
Biopsy

Diagnostic challenges of adult T-cell leukemia/lymphoma in North America – a clinical, histological, and immunophenotypic correlation with a workflow proposal

Licata, M. J., Janakiram, M., Tan, S., Fang, Y., Shah, U. A., Verma, A. K. & Wang, Y. Aug 23 2017 (Accepted/In press) In : Leukemia and Lymphoma. p. 1-7 7 p.

Research output: Research - peer-reviewArticle

Adult T Cell Leukemia Lymphoma
Workflow
North America
Human T-lymphotropic virus 1
T-Lymphocytes
2 Citations
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Neoplasms
Immunotherapy
Adenocarcinoma of lung

Sites of extranodal involvement are prognostic in patients with stage 1 follicular lymphoma

Shastri, A., Janakiram, M., Mantzaris, I., Yu, Y., Londono, J. S., Verma, A. K. & Barta, S. K. 2017 In : Oncotarget. 8, 45, p. 78410-78418 9 p.

Research output: Research - peer-reviewArticle

Follicular Lymphoma
Survival
Confidence Intervals
Rituximab
Therapeutics